Sonoma Pharmaceuticals
SNOA
SNOA
14 hedge funds and large institutions have $27.3K invested in Sonoma Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
50% less capital invested
Capital invested by funds: $54.8K → $27.3K (-$27.5K)
Holders
14
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$7.66K | |
| 2 | +$2.74K | |
| 3 | +$2.24K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$408 |
| 5 |
Wells Fargo
San Francisco,
California
|
+$3 |
Top Sellers
| 1 | -$21.1K | |
| 2 | -$5.96K | |
| 3 | -$5K | |
| 4 |
Millennium Management
New York
|
-$3.14K |
| 5 |
Goldman Sachs
New York
|
-$1.82K |